GE Getting Into the Stem Cell Business

ge logo

General Electric is entering into a venture with Geron Corp to commercially develop products from human embryonic stem cells, including developing sample human cells that drug companies can use to test the toxicity of new drugs.

Geron Corp, a U.S. biotech company, is already devoted to developing and harvesting human embryonic stem cells for various medical therapies. Up to three quarters of toxicity problems are not detected until preclinical or later stages of drug development and this significantly increases the cost of developing new drugs. Earlier detection of toxicity problems could reduce both overall drug development costs and potentially harmful patient exposure in clinical trials.

Related Posts with Thumbnails

Leave a Reply

Contact Us

Tips, Leads, Suggestions, Just Want to Say Hello? Email Dan or Sarah at support (at) stemcellumbilicalcordblood (dot) com